< Back to previous page
Researcher
Isabelle Huys
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Responsible
From17 Dec 2020 → Today - Faculty of Law and Criminology (Faculty)
Member
From1 Oct 2014 → 30 Sep 2015 - Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Jul 2013 → Today - Toxicology and Pharmacology (Division)
Member
From1 Oct 1999 → 9 Mar 2004
Projects
1 - 10 of 50
- Collaborative licensing models for marine genetic resources in striving for efficient, accessible and equitable management of intellectual property rightsFrom12 Feb 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- How to create sustainable market access to advanced therapies?From1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Organoid technologies for disease modeling, drug discovery and development for rare diseasesFrom1 Jan 2024 → TodayFunding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- Sustainable COVID-19 Vaccination for Long-term Vaccine Immunity and EffectivenessFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- Does patient empowerment foster access to and re-use of data in biomedical research, while allowing for meaningful protection of the fundamental right to data protection of patients?From1 Nov 2023 → TodayFunding: FWO junior postdoctoral fellowship
- What are the key factors needed for potential valorization of Marine Natural Products (MNPs)?From1 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Stakeholder Perspectives on Gene Therapy in CardiomyopathyFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Shared decision-making for lung cancer prevention: patient-driven development and evaluation of a decision aid for patients and healthcare providersFrom11 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Shared decision-making for lung cancer prevention: patient-driven development and evaluation of a decision aid for patients and healthcare providersFrom1 Sep 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Patient Experience Data for Innovative TherapiesFrom31 Aug 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
161 - 170 of 213
- Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal Antibodies(2016)
Authors: Evelien Moorkens, Isabelle Huys, Paul Declerck, Steven Simoens, Arnold Vulto
- Intellectual property policies in early-phase research in public–private partnerships(2016)
Authors: Hilde Stevens, Geertrui Van Overwalle, Bart Van Looy, Isabelle Huys
Pages: 504 - 510 - Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs(2016)
Authors: Kim Pauwels, Isabelle Huys, Minne Casteels, Steven Simoens
- Access to bacteriophage therapy: discouraging experiences from the human cell and tissue legal framework(2016)
Authors: Gilbert Verbeken, Isabelle Huys
- Market Uptake Models of Biosimilars and Off-Patent Biological Medicines(2016)
Authors: Evelien Moorkens, N Meuwissen, Isabelle Huys, Arnold Vulto, Paul Declerck, Steven Simoens
Pages: A452 - A452 - Bacteriophage therapy: Fast-forward to the past lessons identified from the advanced therapy regulation(2016)
Authors: Gilbert Verbeken, Isabelle Huys
Pages: 11 - 12 - A bacteriophage journey at the European Medicines Agency(2016)
Authors: Gilbert Verbeken, Isabelle Huys
Pages: 1 - 2 - Qualitative study on custodianship of human biological material and data stored in biobanks(2016)
Authors: Michiel Verlinden, Herman Nys, Nadine Ectors, Isabelle Huys
- Intellectual property rights and regulatory exclusivities in the pharmaceutical sector: challenges and future improvements(2016)
Authors: Stefanie Broes, Sarah Schumacher, Geert Preuveneers, Isabelle Huys
Pages: 19 - 43 - Belgian experiences with drug shortages(2015)
Authors: Elfi De Weerdt, Kim Pauwels, Steven Simoens, Isabelle Huys
Pages: 21 - 24